Valuation
P/E--
P/B--
P/S--
EV/EBIT5.6
Business Strength
ROE0.9%
ROCE4.5%
OPM4.0%
NPM21.9%
Growth (3Y CAGR)
EPS+628.5%
Sales+3.0%
Profit-51.0%
3Y Return--
Balance Sheet
Debt/Equity0.4
Debt549 Cr
Pledge0.0%
CWIP/Fixed Asset71.7%
Cash Position
CFO/NP208.4%
FCF708 Cr
FCF 3Y Avg671 Cr
Cash/MCap636.0%
Others
Div Yield0.0%
Div Payout16.0%
Cash Conv. Cycle192 days
Tradeable Free Float26.1%
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +8.0% | +8.0% | +6.0% | -- | -- | Stable |
| Sales | -- | +10.0% | +3.0% | -- | -30.0% | Decelerating |
| Profit | -- | -27.0% | -51.0% | -- | -85.0% | Decelerating |
| Return | -36.0% | -- | -- | -- | -- | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Debt / Equity0.42
Interest Coverage4.1x
Promoter Pledge0.0%
Borrowings549 Cr
Efficiency
Receivable Days116 days
Inventory Days156 days
Payable Days80 days
Cash Conversion cycle192 days
Cash Position
Operating Cash Flow1.1K Cr
Investing Cash Flow-345 Cr
Financing Cash Flow-786 Cr
Free Cash Flow708 Cr
Detailed Financials
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit Before Tax |
| Tax % |
| Net Profit |
| Exceptional Items |
| EPS (Rs) |
| Sales Growth (YoY) |
| Sales Growth (QoQ) |
| OP Growth (YoY) |
| OP Growth (QoQ) |
| Profit Growth (YoY) |
| EPS Growth (YoY) |
| EPS Growth (QoQ) |
| OP Margin |
| Net Margin |
| Material Cost % |
| Employee Cost % |
| P/S |
| P/E |
| P/B |
Annual Reports
9Credit Ratings
6Concalls
7Aug 2025
31 Aug 2025May 2017
31 May 2017Feb 2017
28 Feb 2017Nov 2016
30 Nov 2016Aug 2016
31 Aug 2016May 2016
31 May 2016Feb 2016
29 Feb 2016